Step 1 topics → Reproductive → Tocolytics (Terbutaline, MgSO4, Nifedipine, Indomethacin)

Tocolytics (Terbutaline, MgSO4, Nifedipine, Indomethacin)

USMLE Step 1 trap: Confuses tocolysis as a short-term bridge for steroids with a strategy to prevent preterm birth. Tocolytics are used to delay delivery by 48 hours to allow corticosteroid administration for fetal lung maturation, not to prevent preterm birth long-term.

Tocolytics are drugs used to suppress uterine contractions in preterm labor. The four agents tested on USMLE Step 1 are terbutaline (β2 agonist), magnesium sulfate, nifedipine (calcium channel blocker), and indomethacin (NSAID/COX inhibitor). Each has a distinct mechanism and a specific contraindication or limitation that the exam loves to probe. The big-picture concept is that tocolysis is not a cure for preterm labor — it buys 48 hours so you can give betamethasone to accelerate fetal lung maturation. That window is the whole point.

USMLE Step 1 tests this in two main ways: first, asking you to pick the right tocolytic given clinical constraints (gestational age, comorbidities, side effect profile), and second, asking why tocolysis is being used at all. The exam will give you a vignette with a patient in preterm labor and bury the key detail — like gestational age being 33 weeks — that should change your drug choice or contraindicate one entirely. Application over recall is the name of the game here.

The tricky part is that students often confuse which drug does what mechanistically and forget that these agents are not interchangeable. Indomethacin has a hard gestational age cutoff. Magnesium sulfate has a dual role (tocolytic AND neuroprotection) that doesn't map cleanly onto 'calcium channel blocker.' Nifedipine actually is a calcium channel blocker, but magnesium's mechanism is different. Keeping these distinctions sharp is what separates a right answer from a trap on USMLE Step 1.

From real student decks
16%have cards covering this topic
11%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: Tocolytics are used to permanently prevent preterm delivery.
Right: Tocolytics are used to delay delivery by 48 hours to allow corticosteroid administration for fetal lung maturation, not to prevent preterm birth long-term.
Tocolytics do not stop preterm birth from happening — the evidence shows they reliably delay delivery by only about 48 hours. That window isn't wasted time; it's specifically used to give corticosteroids (betamethasone) to mature fetal lungs and reduce RDS risk. If you're thinking of tocolytics as a long-term solution to keep the baby in, you'll mismanage both the pharmacology question and any clinical reasoning vignette on the exam.
Common mistake
Gap: Missing that indomethacin is contraindicated after 32 weeks due to risk of premature ductal closure
Indomethacin is contraindicated after 32 weeks gestation because prostaglandin inhibition can cause premature closure of the ductus arteriosus.
Indomethacin inhibits COX and reduces prostaglandin synthesis, which is fine early on, but prostaglandins normally keep the ductus arteriosus open in utero. After 32 weeks, the fetal ductus is increasingly sensitive to prostaglandin withdrawal, so indomethacin can cause premature ductal closure — a serious cardiovascular problem in the fetus. The 32-week cutoff is the testable fact: indomethacin is first-line before 32 weeks, contraindicated after.
Common mistake
Wrong: Magnesium sulfate works as a tocolytic by blocking calcium channels like nifedipine.
Right: Magnesium sulfate acts as a calcium antagonist by competing with calcium at voltage-gated channels and is also used for fetal neuroprotection, not purely as a calcium channel blocker.
Magnesium sulfate is not a calcium channel blocker in the pharmacological sense — it doesn't bind L-type calcium channels the way nifedipine does. Instead, magnesium competes with calcium ions at the channel level because Mg²⁺ and Ca²⁺ are both divalent cations, so high magnesium concentrations functionally antagonize calcium-mediated muscle contraction. More importantly, MgSO4 has a second major role on the exam: fetal neuroprotection against intraventricular hemorrhage and cerebral palsy in premature infants. Nifedipine is the actual L-type CCB in this group.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a clinical scenario, identify the appropriate tocolytic agent and recognize which agent is contraindicated based on gestational age or other clinical factors.
  2. Understand the actual goal of tocolysis — short-term delay of delivery to administer corticosteroids — and identify situations where tocolysis is inappropriate (e.g., fetal distress, chorioamnionitis, maternal instability).

Can you avoid these mistakes?

A patient at 30 weeks gestation presents with preterm labor. You decide to use a tocolytic. What is the primary reason you're giving this medication, and how long do you expect it to work?
You're choosing between nifedipine and indomethacin for tocolysis. Your patient is at 34 weeks. Which drug is contraindicated, and why?
A patient receiving magnesium sulfate for preterm labor asks why she's also getting it when her friend with preterm labor at a different hospital got nifedipine instead. How would you explain the mechanism difference between MgSO4 and nifedipine — and what additional benefit does MgSO4 offer that nifedipine doesn't?
In which clinical situations is tocolysis absolutely NOT indicated, even if the patient appears to be in preterm labor?

Related topics

Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →